1. Home
  2. IRWD vs PRTH Comparison

IRWD vs PRTH Comparison

Compare IRWD & PRTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRWD
  • PRTH
  • Stock Information
  • Founded
  • IRWD 1998
  • PRTH 2005
  • Country
  • IRWD United States
  • PRTH United States
  • Employees
  • IRWD N/A
  • PRTH 983
  • Industry
  • IRWD Biotechnology: Pharmaceutical Preparations
  • PRTH EDP Services
  • Sector
  • IRWD Health Care
  • PRTH Technology
  • Exchange
  • IRWD Nasdaq
  • PRTH Nasdaq
  • Market Cap
  • IRWD 716.9M
  • PRTH 613.9M
  • IPO Year
  • IRWD 2010
  • PRTH N/A
  • Fundamental
  • Price
  • IRWD $4.21
  • PRTH $7.99
  • Analyst Decision
  • IRWD Buy
  • PRTH Buy
  • Analyst Count
  • IRWD 4
  • PRTH 2
  • Target Price
  • IRWD $12.00
  • PRTH $11.00
  • AVG Volume (30 Days)
  • IRWD 1.4M
  • PRTH 114.4K
  • Earning Date
  • IRWD 11-07-2024
  • PRTH 11-07-2024
  • Dividend Yield
  • IRWD N/A
  • PRTH N/A
  • EPS Growth
  • IRWD N/A
  • PRTH N/A
  • EPS
  • IRWD N/A
  • PRTH N/A
  • Revenue
  • IRWD $378,418,000.00
  • PRTH $851,914,000.00
  • Revenue This Year
  • IRWD N/A
  • PRTH $18.77
  • Revenue Next Year
  • IRWD N/A
  • PRTH $11.36
  • P/E Ratio
  • IRWD N/A
  • PRTH N/A
  • Revenue Growth
  • IRWD N/A
  • PRTH 16.08
  • 52 Week Low
  • IRWD $3.79
  • PRTH $2.79
  • 52 Week High
  • IRWD $15.70
  • PRTH $8.90
  • Technical
  • Relative Strength Index (RSI)
  • IRWD 46.85
  • PRTH 67.23
  • Support Level
  • IRWD $4.26
  • PRTH $5.01
  • Resistance Level
  • IRWD $5.07
  • PRTH $8.90
  • Average True Range (ATR)
  • IRWD 0.32
  • PRTH 0.50
  • MACD
  • IRWD -0.02
  • PRTH 0.29
  • Stochastic Oscillator
  • IRWD 24.56
  • PRTH 76.61

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

About PRTH Priority Technology Holdings Inc.

Priority Technology Holdings Inc is a provider of merchant acquiring and commercial payment solutions to small and medium businesses enterprises in the United States. The company has three reportable segments which are SMB Payments, B2B Payments and Enterprise Payments. SMB Payments segment which generates majority revenue provides full-service acquiring and payment-enabled solutions for B2C transactions, leveraging priority's proprietary software platform, distributed through ISO; B2B Payments segment provides AP automation solutions to corporations, software partners and industry FIs: and Enterprise Payments segment provides embedded payment and treasury solutions to enterprise customers to modernize legacy platforms and accelerate software partners' strategies to monetize payments.

Share on Social Networks: